Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001033427-00-000019
Filing Date
2000-02-07
Accepted
2000-02-07 00:00:00
Documents
2
Group Members
CL INVESTORS, INC.COLE PARTNERS LLCDAVID L. COHENHAROLD J. LEVYIRIDIAN ASSET MANAGEMENT LLC/CTIRIDIAN PARTNERS FUND, L.P.IRIDIAN PRIVATE BUSINESS VALUE EQUITY FUND, L.P.LC CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 34591
2 JOINT FILING AGREEMENT EX-99 3731
  Complete submission text file 0001033427-00-000019.txt   40653
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

EIN.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37205 | Film No.: 525142
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST RD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

EIN.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231